Innovative thermoresponsive nanoparticle-laden hydrogel offering localized, sustained drug release for neuropathic pain. This biodegradable solution enhances drug penetration, minimizes systemic exposure, and improves efficacy, addressing current treatment limitations.
The innovative nanoparticle-laden hydrogel offers a breakthrough in neuropathic pain management by addressing the significant limitations of current treatments, such as systemic side effects and poor targeted delivery. This solution utilizes a thermoresponsive, biodegradable gel designed for localized and sustained drug release, significantly improving efficacy and safety. The hydrogel encapsulates precisely engineered nanoparticles loaded with analgesic and anti-inflammatory compounds, enhancing drug penetration and retention at the pain site, thus ensuring more effective and sustained relief.
Key features:
This technology is currently at Technology Readiness Level 4. The development phase includes nanoparticle and hydrogel design and optimization, followed by preclinical efficacy and safety evaluation. The upcoming phase will focus on in vitro and in vivo assessments to validate therapeutic efficacy, safety, and biodistribution.
Deraya University is a growing private institution in Upper Egypt serving New Minya and the surrounding region with an emphasis on applied learning and community impact. Co-located teaching and research labs, on-campus health clinics, and an applied sustainability center enable hands-on collaboration with external partners. Clinical links, including a training protocol with Baheya Hospital, provide real-world environments for translation and workforce development. Research activity is supported by competitive national programs and international collaborations. A dedicated continuing-education academy, delivered with recognized external organizations, offers professional upskilling and supports knowledge transfer.